nodes	percent_of_prediction	percent_of_DWPC	metapath
Amobarbital—CYP2A6—stomach cancer	0.872	1	CbGaD
Amobarbital—Injection site reaction—Mitomycin—stomach cancer	0.00444	0.0373	CcSEcCtD
Amobarbital—Anaemia megaloblastic—Methotrexate—stomach cancer	0.0041	0.0345	CcSEcCtD
Amobarbital—Pneumothorax—Capecitabine—stomach cancer	0.00261	0.0219	CcSEcCtD
Amobarbital—Confusional state—Floxuridine—stomach cancer	0.00205	0.0172	CcSEcCtD
Amobarbital—Pneumothorax—Epirubicin—stomach cancer	0.00182	0.0153	CcSEcCtD
Amobarbital—Syncope—Mitomycin—stomach cancer	0.00175	0.0147	CcSEcCtD
Amobarbital—Loss of consciousness—Mitomycin—stomach cancer	0.00171	0.0144	CcSEcCtD
Amobarbital—Pneumothorax—Doxorubicin—stomach cancer	0.00168	0.0141	CcSEcCtD
Amobarbital—Feeling abnormal—Floxuridine—stomach cancer	0.00167	0.0141	CcSEcCtD
Amobarbital—Confusional state—Mitomycin—stomach cancer	0.0016	0.0135	CcSEcCtD
Amobarbital—Body temperature increased—Floxuridine—stomach cancer	0.0016	0.0135	CcSEcCtD
Amobarbital—Shock—Mitomycin—stomach cancer	0.00157	0.0132	CcSEcCtD
Amobarbital—Hypoxia—Methotrexate—stomach cancer	0.00152	0.0128	CcSEcCtD
Amobarbital—Hypersensitivity—Floxuridine—stomach cancer	0.00149	0.0126	CcSEcCtD
Amobarbital—Dermatitis exfoliative—Irinotecan—stomach cancer	0.00149	0.0125	CcSEcCtD
Amobarbital—Somnolence—Mitomycin—stomach cancer	0.00142	0.0119	CcSEcCtD
Amobarbital—Respiratory failure—Docetaxel—stomach cancer	0.00136	0.0115	CcSEcCtD
Amobarbital—Hepatocellular injury—Docetaxel—stomach cancer	0.00134	0.0113	CcSEcCtD
Amobarbital—Injection site reaction—Docetaxel—stomach cancer	0.00133	0.0112	CcSEcCtD
Amobarbital—Feeling abnormal—Mitomycin—stomach cancer	0.00131	0.011	CcSEcCtD
Amobarbital—Vomiting—Floxuridine—stomach cancer	0.00129	0.0109	CcSEcCtD
Amobarbital—Injection site reaction—Capecitabine—stomach cancer	0.00129	0.0109	CcSEcCtD
Amobarbital—Rash—Floxuridine—stomach cancer	0.00128	0.0108	CcSEcCtD
Amobarbital—Dermatitis—Floxuridine—stomach cancer	0.00128	0.0108	CcSEcCtD
Amobarbital—Headache—Floxuridine—stomach cancer	0.00127	0.0107	CcSEcCtD
Amobarbital—Ataxia—Fluorouracil—stomach cancer	0.00127	0.0107	CcSEcCtD
Amobarbital—Body temperature increased—Mitomycin—stomach cancer	0.00126	0.0106	CcSEcCtD
Amobarbital—Depressed level of consciousness—Capecitabine—stomach cancer	0.00125	0.0105	CcSEcCtD
Amobarbital—Nausea—Floxuridine—stomach cancer	0.0012	0.0101	CcSEcCtD
Amobarbital—Apnoea—Methotrexate—stomach cancer	0.00114	0.00959	CcSEcCtD
Amobarbital—Mental disability—Capecitabine—stomach cancer	0.00113	0.00947	CcSEcCtD
Amobarbital—Liver injury—Epirubicin—stomach cancer	0.00107	0.00904	CcSEcCtD
Amobarbital—Dizziness—Mitomycin—stomach cancer	0.00105	0.00886	CcSEcCtD
Amobarbital—Vomiting—Mitomycin—stomach cancer	0.00101	0.00852	CcSEcCtD
Amobarbital—Rash—Mitomycin—stomach cancer	0.001	0.00845	CcSEcCtD
Amobarbital—Dermatitis—Mitomycin—stomach cancer	0.001	0.00844	CcSEcCtD
Amobarbital—Dermatitis exfoliative—Capecitabine—stomach cancer	0.000998	0.0084	CcSEcCtD
Amobarbital—Headache—Mitomycin—stomach cancer	0.000997	0.00839	CcSEcCtD
Amobarbital—Liver injury—Doxorubicin—stomach cancer	0.000993	0.00836	CcSEcCtD
Amobarbital—Bradycardia—Irinotecan—stomach cancer	0.000991	0.00834	CcSEcCtD
Amobarbital—Thinking abnormal—Epirubicin—stomach cancer	0.000987	0.00831	CcSEcCtD
Amobarbital—Respiratory failure—Methotrexate—stomach cancer	0.000983	0.00828	CcSEcCtD
Amobarbital—Nausea—Mitomycin—stomach cancer	0.000945	0.00796	CcSEcCtD
Amobarbital—Depressed level of consciousness—Methotrexate—stomach cancer	0.000932	0.00785	CcSEcCtD
Amobarbital—Ataxia—Docetaxel—stomach cancer	0.000914	0.0077	CcSEcCtD
Amobarbital—Thinking abnormal—Doxorubicin—stomach cancer	0.000913	0.00769	CcSEcCtD
Amobarbital—Hepatocellular injury—Epirubicin—stomach cancer	0.000903	0.00761	CcSEcCtD
Amobarbital—Injection site reaction—Epirubicin—stomach cancer	0.000898	0.00756	CcSEcCtD
Amobarbital—Ataxia—Capecitabine—stomach cancer	0.000885	0.00745	CcSEcCtD
Amobarbital—Hepatocellular injury—Doxorubicin—stomach cancer	0.000836	0.00704	CcSEcCtD
Amobarbital—Injection site reaction—Doxorubicin—stomach cancer	0.000831	0.007	CcSEcCtD
Amobarbital—Mental disability—Epirubicin—stomach cancer	0.000784	0.0066	CcSEcCtD
Amobarbital—Syncope—Irinotecan—stomach cancer	0.00076	0.00639	CcSEcCtD
Amobarbital—Loss of consciousness—Irinotecan—stomach cancer	0.000744	0.00627	CcSEcCtD
Amobarbital—Dermatitis exfoliative—Methotrexate—stomach cancer	0.000743	0.00625	CcSEcCtD
Amobarbital—Mental disability—Doxorubicin—stomach cancer	0.000725	0.00611	CcSEcCtD
Amobarbital—Confusional state—Irinotecan—stomach cancer	0.000697	0.00587	CcSEcCtD
Amobarbital—Dermatitis exfoliative—Epirubicin—stomach cancer	0.000695	0.00585	CcSEcCtD
Amobarbital—Shock—Irinotecan—stomach cancer	0.00068	0.00573	CcSEcCtD
Amobarbital—Confusional state—Fluorouracil—stomach cancer	0.000668	0.00562	CcSEcCtD
Amobarbital—Bradycardia—Capecitabine—stomach cancer	0.000663	0.00558	CcSEcCtD
Amobarbital—Ataxia—Methotrexate—stomach cancer	0.000659	0.00555	CcSEcCtD
Amobarbital—Hypotension—Irinotecan—stomach cancer	0.000646	0.00544	CcSEcCtD
Amobarbital—Dermatitis exfoliative—Doxorubicin—stomach cancer	0.000643	0.00541	CcSEcCtD
Amobarbital—Hypotension—Fluorouracil—stomach cancer	0.000619	0.00521	CcSEcCtD
Amobarbital—Ataxia—Epirubicin—stomach cancer	0.000617	0.00519	CcSEcCtD
Amobarbital—Somnolence—Irinotecan—stomach cancer	0.000615	0.00517	CcSEcCtD
Amobarbital—Constipation—Irinotecan—stomach cancer	0.000591	0.00498	CcSEcCtD
Amobarbital—Somnolence—Fluorouracil—stomach cancer	0.000589	0.00495	CcSEcCtD
Amobarbital—Ataxia—Doxorubicin—stomach cancer	0.000571	0.0048	CcSEcCtD
Amobarbital—Feeling abnormal—Irinotecan—stomach cancer	0.00057	0.0048	CcSEcCtD
Amobarbital—Body temperature increased—Irinotecan—stomach cancer	0.000546	0.0046	CcSEcCtD
Amobarbital—Feeling abnormal—Fluorouracil—stomach cancer	0.000546	0.00459	CcSEcCtD
Amobarbital—Syncope—Docetaxel—stomach cancer	0.000525	0.00442	CcSEcCtD
Amobarbital—Body temperature increased—Fluorouracil—stomach cancer	0.000523	0.00441	CcSEcCtD
Amobarbital—Loss of consciousness—Docetaxel—stomach cancer	0.000515	0.00433	CcSEcCtD
Amobarbital—Hypersensitivity—Irinotecan—stomach cancer	0.000509	0.00429	CcSEcCtD
Amobarbital—Syncope—Capecitabine—stomach cancer	0.000508	0.00428	CcSEcCtD
Amobarbital—Loss of consciousness—Capecitabine—stomach cancer	0.000498	0.00419	CcSEcCtD
Amobarbital—Hypersensitivity—Fluorouracil—stomach cancer	0.000488	0.00411	CcSEcCtD
Amobarbital—Confusional state—Docetaxel—stomach cancer	0.000482	0.00406	CcSEcCtD
Amobarbital—Anxiety—Capecitabine—stomach cancer	0.000481	0.00405	CcSEcCtD
Amobarbital—Shock—Docetaxel—stomach cancer	0.00047	0.00396	CcSEcCtD
Amobarbital—Confusional state—Capecitabine—stomach cancer	0.000467	0.00393	CcSEcCtD
Amobarbital—Bradycardia—Epirubicin—stomach cancer	0.000462	0.00389	CcSEcCtD
Amobarbital—Dizziness—Irinotecan—stomach cancer	0.000457	0.00385	CcSEcCtD
Amobarbital—Shock—Capecitabine—stomach cancer	0.000455	0.00383	CcSEcCtD
Amobarbital—Hypotension—Docetaxel—stomach cancer	0.000447	0.00376	CcSEcCtD
Amobarbital—Vomiting—Irinotecan—stomach cancer	0.00044	0.0037	CcSEcCtD
Amobarbital—Dizziness—Fluorouracil—stomach cancer	0.000438	0.00369	CcSEcCtD
Amobarbital—Rash—Irinotecan—stomach cancer	0.000436	0.00367	CcSEcCtD
Amobarbital—Dermatitis—Irinotecan—stomach cancer	0.000435	0.00367	CcSEcCtD
Amobarbital—Headache—Irinotecan—stomach cancer	0.000433	0.00365	CcSEcCtD
Amobarbital—Hypotension—Capecitabine—stomach cancer	0.000432	0.00364	CcSEcCtD
Amobarbital—Bradycardia—Doxorubicin—stomach cancer	0.000427	0.0036	CcSEcCtD
Amobarbital—Somnolence—Docetaxel—stomach cancer	0.000425	0.00358	CcSEcCtD
Amobarbital—Vomiting—Fluorouracil—stomach cancer	0.000421	0.00354	CcSEcCtD
Amobarbital—Rash—Fluorouracil—stomach cancer	0.000417	0.00351	CcSEcCtD
Amobarbital—Dermatitis—Fluorouracil—stomach cancer	0.000417	0.00351	CcSEcCtD
Amobarbital—Headache—Fluorouracil—stomach cancer	0.000415	0.00349	CcSEcCtD
Amobarbital—Nausea—Irinotecan—stomach cancer	0.000411	0.00346	CcSEcCtD
Amobarbital—Constipation—Docetaxel—stomach cancer	0.000409	0.00344	CcSEcCtD
Amobarbital—Constipation—Capecitabine—stomach cancer	0.000396	0.00333	CcSEcCtD
Amobarbital—Feeling abnormal—Docetaxel—stomach cancer	0.000394	0.00331	CcSEcCtD
Amobarbital—Nausea—Fluorouracil—stomach cancer	0.000393	0.00331	CcSEcCtD
Amobarbital—Tension—Epirubicin—stomach cancer	0.000388	0.00326	CcSEcCtD
Amobarbital—Nervousness—Epirubicin—stomach cancer	0.000384	0.00323	CcSEcCtD
Amobarbital—Feeling abnormal—Capecitabine—stomach cancer	0.000381	0.00321	CcSEcCtD
Amobarbital—Body temperature increased—Docetaxel—stomach cancer	0.000378	0.00318	CcSEcCtD
Amobarbital—Body temperature increased—Capecitabine—stomach cancer	0.000366	0.00308	CcSEcCtD
Amobarbital—Agitation—Epirubicin—stomach cancer	0.000363	0.00306	CcSEcCtD
Amobarbital—Tension—Doxorubicin—stomach cancer	0.000359	0.00302	CcSEcCtD
Amobarbital—Nervousness—Doxorubicin—stomach cancer	0.000355	0.00299	CcSEcCtD
Amobarbital—Syncope—Epirubicin—stomach cancer	0.000354	0.00298	CcSEcCtD
Amobarbital—Hypersensitivity—Docetaxel—stomach cancer	0.000352	0.00296	CcSEcCtD
Amobarbital—Confusional state—Methotrexate—stomach cancer	0.000347	0.00292	CcSEcCtD
Amobarbital—Loss of consciousness—Epirubicin—stomach cancer	0.000347	0.00292	CcSEcCtD
Amobarbital—Hypersensitivity—Capecitabine—stomach cancer	0.000341	0.00287	CcSEcCtD
Amobarbital—Agitation—Doxorubicin—stomach cancer	0.000336	0.00283	CcSEcCtD
Amobarbital—Anxiety—Epirubicin—stomach cancer	0.000335	0.00282	CcSEcCtD
Amobarbital—Syncope—Doxorubicin—stomach cancer	0.000328	0.00276	CcSEcCtD
Amobarbital—Confusional state—Epirubicin—stomach cancer	0.000325	0.00274	CcSEcCtD
Amobarbital—Hypotension—Methotrexate—stomach cancer	0.000322	0.00271	CcSEcCtD
Amobarbital—Loss of consciousness—Doxorubicin—stomach cancer	0.000321	0.0027	CcSEcCtD
Amobarbital—Shock—Epirubicin—stomach cancer	0.000317	0.00267	CcSEcCtD
Amobarbital—Dizziness—Docetaxel—stomach cancer	0.000316	0.00266	CcSEcCtD
Amobarbital—Anxiety—Doxorubicin—stomach cancer	0.00031	0.00261	CcSEcCtD
Amobarbital—Somnolence—Methotrexate—stomach cancer	0.000306	0.00258	CcSEcCtD
Amobarbital—Dizziness—Capecitabine—stomach cancer	0.000306	0.00258	CcSEcCtD
Amobarbital—Vomiting—Docetaxel—stomach cancer	0.000304	0.00256	CcSEcCtD
Amobarbital—Rash—Docetaxel—stomach cancer	0.000301	0.00254	CcSEcCtD
Amobarbital—Hypotension—Epirubicin—stomach cancer	0.000301	0.00254	CcSEcCtD
Amobarbital—Dermatitis—Docetaxel—stomach cancer	0.000301	0.00253	CcSEcCtD
Amobarbital—Confusional state—Doxorubicin—stomach cancer	0.000301	0.00253	CcSEcCtD
Amobarbital—Headache—Docetaxel—stomach cancer	0.000299	0.00252	CcSEcCtD
Amobarbital—Vomiting—Capecitabine—stomach cancer	0.000294	0.00248	CcSEcCtD
Amobarbital—Shock—Doxorubicin—stomach cancer	0.000293	0.00247	CcSEcCtD
Amobarbital—Rash—Capecitabine—stomach cancer	0.000292	0.00246	CcSEcCtD
Amobarbital—Dermatitis—Capecitabine—stomach cancer	0.000291	0.00245	CcSEcCtD
Amobarbital—Headache—Capecitabine—stomach cancer	0.00029	0.00244	CcSEcCtD
Amobarbital—Somnolence—Epirubicin—stomach cancer	0.000287	0.00241	CcSEcCtD
Amobarbital—Nausea—Docetaxel—stomach cancer	0.000284	0.00239	CcSEcCtD
Amobarbital—Feeling abnormal—Methotrexate—stomach cancer	0.000284	0.00239	CcSEcCtD
Amobarbital—Hypotension—Doxorubicin—stomach cancer	0.000279	0.00235	CcSEcCtD
Amobarbital—Constipation—Epirubicin—stomach cancer	0.000276	0.00232	CcSEcCtD
Amobarbital—Nausea—Capecitabine—stomach cancer	0.000275	0.00231	CcSEcCtD
Amobarbital—Body temperature increased—Methotrexate—stomach cancer	0.000272	0.00229	CcSEcCtD
Amobarbital—Feeling abnormal—Epirubicin—stomach cancer	0.000266	0.00224	CcSEcCtD
Amobarbital—Somnolence—Doxorubicin—stomach cancer	0.000265	0.00223	CcSEcCtD
Amobarbital—Constipation—Doxorubicin—stomach cancer	0.000255	0.00215	CcSEcCtD
Amobarbital—Body temperature increased—Epirubicin—stomach cancer	0.000255	0.00214	CcSEcCtD
Amobarbital—Hypersensitivity—Methotrexate—stomach cancer	0.000254	0.00214	CcSEcCtD
Amobarbital—Feeling abnormal—Doxorubicin—stomach cancer	0.000246	0.00207	CcSEcCtD
Amobarbital—Hypersensitivity—Epirubicin—stomach cancer	0.000237	0.002	CcSEcCtD
Amobarbital—Body temperature increased—Doxorubicin—stomach cancer	0.000236	0.00198	CcSEcCtD
Amobarbital—Dizziness—Methotrexate—stomach cancer	0.000228	0.00192	CcSEcCtD
Amobarbital—Hypersensitivity—Doxorubicin—stomach cancer	0.00022	0.00185	CcSEcCtD
Amobarbital—Vomiting—Methotrexate—stomach cancer	0.000219	0.00184	CcSEcCtD
Amobarbital—Rash—Methotrexate—stomach cancer	0.000217	0.00183	CcSEcCtD
Amobarbital—Dermatitis—Methotrexate—stomach cancer	0.000217	0.00183	CcSEcCtD
Amobarbital—Headache—Methotrexate—stomach cancer	0.000216	0.00182	CcSEcCtD
Amobarbital—Dizziness—Epirubicin—stomach cancer	0.000213	0.00179	CcSEcCtD
Amobarbital—Vomiting—Epirubicin—stomach cancer	0.000205	0.00173	CcSEcCtD
Amobarbital—Nausea—Methotrexate—stomach cancer	0.000205	0.00172	CcSEcCtD
Amobarbital—Rash—Epirubicin—stomach cancer	0.000203	0.00171	CcSEcCtD
Amobarbital—Dermatitis—Epirubicin—stomach cancer	0.000203	0.00171	CcSEcCtD
Amobarbital—Headache—Epirubicin—stomach cancer	0.000202	0.0017	CcSEcCtD
Amobarbital—Dizziness—Doxorubicin—stomach cancer	0.000197	0.00166	CcSEcCtD
Amobarbital—Nausea—Epirubicin—stomach cancer	0.000191	0.00161	CcSEcCtD
Amobarbital—Vomiting—Doxorubicin—stomach cancer	0.00019	0.0016	CcSEcCtD
Amobarbital—Rash—Doxorubicin—stomach cancer	0.000188	0.00158	CcSEcCtD
Amobarbital—Dermatitis—Doxorubicin—stomach cancer	0.000188	0.00158	CcSEcCtD
Amobarbital—Headache—Doxorubicin—stomach cancer	0.000187	0.00157	CcSEcCtD
Amobarbital—Nausea—Doxorubicin—stomach cancer	0.000177	0.00149	CcSEcCtD
Amobarbital—GABRA3—Transmission across Chemical Synapses—SLC1A2—stomach cancer	5.27e-05	0.00559	CbGpPWpGaD
Amobarbital—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—stomach cancer	5.24e-05	0.00555	CbGpPWpGaD
Amobarbital—CHRNA7—Transmission across Chemical Synapses—HSPA8—stomach cancer	5.23e-05	0.00554	CbGpPWpGaD
Amobarbital—GABRA2—Transmission across Chemical Synapses—SLC1A2—stomach cancer	5.18e-05	0.00549	CbGpPWpGaD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—IL1RN—stomach cancer	5.11e-05	0.00541	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—CLCN3—stomach cancer	5.08e-05	0.00539	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—CLCN3—stomach cancer	4.99e-05	0.00529	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—CLCN3—stomach cancer	4.9e-05	0.0052	CbGpPWpGaD
Amobarbital—CHRNA7—SIDS Susceptibility Pathways—BDNF—stomach cancer	4.7e-05	0.00498	CbGpPWpGaD
Amobarbital—GABRA6—Neuronal System—SLC1A2—stomach cancer	4.69e-05	0.00497	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—RORA—stomach cancer	4.69e-05	0.00497	CbGpPWpGaD
Amobarbital—GABRA4—Neuronal System—SLC1A2—stomach cancer	4.63e-05	0.00491	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—RUNX3—stomach cancer	4.58e-05	0.00486	CbGpPWpGaD
Amobarbital—CHRNA7—SIDS Susceptibility Pathways—IL10—stomach cancer	4.48e-05	0.00475	CbGpPWpGaD
Amobarbital—GABRA1—Transmission across Chemical Synapses—SLC1A2—stomach cancer	4.42e-05	0.00468	CbGpPWpGaD
Amobarbital—GRIK2—Neuronal System—HSPA8—stomach cancer	4.4e-05	0.00467	CbGpPWpGaD
Amobarbital—GRIA2—Transmission across Chemical Synapses—HSPA8—stomach cancer	4.4e-05	0.00466	CbGpPWpGaD
Amobarbital—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—MAPK1—stomach cancer	4.39e-05	0.00465	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—HSPD1—stomach cancer	4.31e-05	0.00457	CbGpPWpGaD
Amobarbital—CHRNA4—Transmission across Chemical Synapses—HSPA8—stomach cancer	4.26e-05	0.00452	CbGpPWpGaD
Amobarbital—GRIA2—N-cadherin signaling events—PIK3CA—stomach cancer	4.22e-05	0.00448	CbGpPWpGaD
Amobarbital—GRIA2—BDNF signaling pathway—BDNF—stomach cancer	4.21e-05	0.00446	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—CLCN3—stomach cancer	4.18e-05	0.00443	CbGpPWpGaD
Amobarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—stomach cancer	4.17e-05	0.00442	CbGpPWpGaD
Amobarbital—GABRA5—Neuronal System—SLC1A2—stomach cancer	4.11e-05	0.00436	CbGpPWpGaD
Amobarbital—GABRA3—Neuronal System—SLC1A2—stomach cancer	4.04e-05	0.00428	CbGpPWpGaD
Amobarbital—CHRNA7—Neuronal System—HSPA8—stomach cancer	4.01e-05	0.00425	CbGpPWpGaD
Amobarbital—GABRA2—Neuronal System—SLC1A2—stomach cancer	3.97e-05	0.00421	CbGpPWpGaD
Amobarbital—GRIA2—BDNF signaling pathway—FYN—stomach cancer	3.93e-05	0.00417	CbGpPWpGaD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—BDNF—stomach cancer	3.83e-05	0.00406	CbGpPWpGaD
Amobarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—stomach cancer	3.79e-05	0.00402	CbGpPWpGaD
Amobarbital—GABRA6—Transmission across Chemical Synapses—HSPA8—stomach cancer	3.66e-05	0.00387	CbGpPWpGaD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—IL10—stomach cancer	3.66e-05	0.00387	CbGpPWpGaD
Amobarbital—GABRA4—Transmission across Chemical Synapses—HSPA8—stomach cancer	3.61e-05	0.00383	CbGpPWpGaD
Amobarbital—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—stomach cancer	3.52e-05	0.00373	CbGpPWpGaD
Amobarbital—CYP2A6—NRF2 pathway—TGFA—stomach cancer	3.46e-05	0.00367	CbGpPWpGaD
Amobarbital—CYP2A6—NRF2 pathway—SERPINA1—stomach cancer	3.41e-05	0.00362	CbGpPWpGaD
Amobarbital—GABRA1—Neuronal System—SLC1A2—stomach cancer	3.38e-05	0.00359	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—HTR1A—stomach cancer	3.38e-05	0.00358	CbGpPWpGaD
Amobarbital—GRIA2—BDNF signaling pathway—IRS2—stomach cancer	3.38e-05	0.00358	CbGpPWpGaD
Amobarbital—GRIA2—Neuronal System—HSPA8—stomach cancer	3.37e-05	0.00357	CbGpPWpGaD
Amobarbital—CHRNA4—Neuronal System—HSPA8—stomach cancer	3.27e-05	0.00346	CbGpPWpGaD
Amobarbital—GABRA5—Transmission across Chemical Synapses—HSPA8—stomach cancer	3.21e-05	0.0034	CbGpPWpGaD
Amobarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—stomach cancer	3.19e-05	0.00338	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—IL1RN—stomach cancer	3.16e-05	0.00335	CbGpPWpGaD
Amobarbital—GABRA3—Transmission across Chemical Synapses—HSPA8—stomach cancer	3.15e-05	0.00334	CbGpPWpGaD
Amobarbital—GRIK2—Transmission across Chemical Synapses—PRKCB—stomach cancer	3.13e-05	0.00332	CbGpPWpGaD
Amobarbital—GABRA2—Transmission across Chemical Synapses—HSPA8—stomach cancer	3.09e-05	0.00328	CbGpPWpGaD
Amobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—stomach cancer	3.09e-05	0.00328	CbGpPWpGaD
Amobarbital—CHRNA7—SIDS Susceptibility Pathways—IL6R—stomach cancer	3.09e-05	0.00328	CbGpPWpGaD
Amobarbital—GRIA2—BDNF signaling pathway—APC—stomach cancer	2.98e-05	0.00316	CbGpPWpGaD
Amobarbital—CHRNA7—Transmission across Chemical Synapses—PRKCB—stomach cancer	2.85e-05	0.00302	CbGpPWpGaD
Amobarbital—GABRA6—Neuronal System—HSPA8—stomach cancer	2.8e-05	0.00297	CbGpPWpGaD
Amobarbital—CYP2A6—Biological oxidations—GSTT1—stomach cancer	2.77e-05	0.00294	CbGpPWpGaD
Amobarbital—GABRA4—Neuronal System—HSPA8—stomach cancer	2.77e-05	0.00293	CbGpPWpGaD
Amobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—stomach cancer	2.65e-05	0.00281	CbGpPWpGaD
Amobarbital—GABRA1—Transmission across Chemical Synapses—HSPA8—stomach cancer	2.64e-05	0.0028	CbGpPWpGaD
Amobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—stomach cancer	2.62e-05	0.00278	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—SLC1A2—stomach cancer	2.52e-05	0.00267	CbGpPWpGaD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—IL6R—stomach cancer	2.52e-05	0.00267	CbGpPWpGaD
Amobarbital—GABRA4—Transmembrane transport of small molecules—SLC1A2—stomach cancer	2.49e-05	0.00264	CbGpPWpGaD
Amobarbital—CYP2A6—NRF2 pathway—HBEGF—stomach cancer	2.47e-05	0.00262	CbGpPWpGaD
Amobarbital—GABRA5—Neuronal System—HSPA8—stomach cancer	2.46e-05	0.0026	CbGpPWpGaD
Amobarbital—CHRNA7—SIDS Susceptibility Pathways—CXCL8—stomach cancer	2.45e-05	0.0026	CbGpPWpGaD
Amobarbital—GABRA3—Neuronal System—HSPA8—stomach cancer	2.41e-05	0.00256	CbGpPWpGaD
Amobarbital—GRIK2—Neuronal System—PRKCB—stomach cancer	2.4e-05	0.00255	CbGpPWpGaD
Amobarbital—GRIA2—Transmission across Chemical Synapses—PRKCB—stomach cancer	2.4e-05	0.00254	CbGpPWpGaD
Amobarbital—GABRA2—Neuronal System—HSPA8—stomach cancer	2.37e-05	0.00251	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—BDNF—stomach cancer	2.37e-05	0.00251	CbGpPWpGaD
Amobarbital—CHRNA7—SIDS Susceptibility Pathways—IL1B—stomach cancer	2.35e-05	0.00249	CbGpPWpGaD
Amobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—stomach cancer	2.33e-05	0.00247	CbGpPWpGaD
Amobarbital—CHRNA4—Transmission across Chemical Synapses—PRKCB—stomach cancer	2.32e-05	0.00246	CbGpPWpGaD
Amobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—stomach cancer	2.28e-05	0.00242	CbGpPWpGaD
Amobarbital—CHRNA7—SIDS Susceptibility Pathways—JUN—stomach cancer	2.28e-05	0.00242	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—IL10—stomach cancer	2.26e-05	0.0024	CbGpPWpGaD
Amobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—stomach cancer	2.25e-05	0.00238	CbGpPWpGaD
Amobarbital—CYP2A6—Fluoropyrimidine Activity—TP53—stomach cancer	2.22e-05	0.00235	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—SLC1A2—stomach cancer	2.21e-05	0.00234	CbGpPWpGaD
Amobarbital—CYP2A6—NRF2 pathway—GSTP1—stomach cancer	2.19e-05	0.00232	CbGpPWpGaD
Amobarbital—CHRNA7—Neuronal System—PRKCB—stomach cancer	2.19e-05	0.00232	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—SLC1A2—stomach cancer	2.17e-05	0.0023	CbGpPWpGaD
Amobarbital—CYP2A6—NRF2 pathway—HMOX1—stomach cancer	2.16e-05	0.00229	CbGpPWpGaD
Amobarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—stomach cancer	2.15e-05	0.00228	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—SLC1A2—stomach cancer	2.13e-05	0.00226	CbGpPWpGaD
Amobarbital—GRIA2—BDNF signaling pathway—JUN—stomach cancer	2.04e-05	0.00217	CbGpPWpGaD
Amobarbital—GABRA1—Neuronal System—HSPA8—stomach cancer	2.02e-05	0.00214	CbGpPWpGaD
Amobarbital—CYP2A6—NRF2 pathway—GSTM1—stomach cancer	2.01e-05	0.00213	CbGpPWpGaD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—CXCL8—stomach cancer	2e-05	0.00212	CbGpPWpGaD
Amobarbital—GABRA6—Transmission across Chemical Synapses—PRKCB—stomach cancer	1.99e-05	0.00211	CbGpPWpGaD
Amobarbital—CHRNA7—SIDS Susceptibility Pathways—VEGFA—stomach cancer	1.99e-05	0.00211	CbGpPWpGaD
Amobarbital—GABRA4—Transmission across Chemical Synapses—PRKCB—stomach cancer	1.97e-05	0.00209	CbGpPWpGaD
Amobarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—stomach cancer	1.95e-05	0.00207	CbGpPWpGaD
Amobarbital—GRIA2—BDNF signaling pathway—MAPK8—stomach cancer	1.93e-05	0.00205	CbGpPWpGaD
Amobarbital—CYP2A6—Biological oxidations—GSTP1—stomach cancer	1.92e-05	0.00203	CbGpPWpGaD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—IL1B—stomach cancer	1.92e-05	0.00203	CbGpPWpGaD
Amobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—stomach cancer	1.91e-05	0.00203	CbGpPWpGaD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—JUN—stomach cancer	1.86e-05	0.00197	CbGpPWpGaD
Amobarbital—GRIA2—Neuronal System—PRKCB—stomach cancer	1.84e-05	0.00195	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—SLC1A2—stomach cancer	1.82e-05	0.00193	CbGpPWpGaD
Amobarbital—CHRNA4—Neuronal System—PRKCB—stomach cancer	1.78e-05	0.00189	CbGpPWpGaD
Amobarbital—GRIA2—BDNF signaling pathway—STAT3—stomach cancer	1.77e-05	0.00187	CbGpPWpGaD
Amobarbital—CYP2A6—Biological oxidations—GSTM1—stomach cancer	1.76e-05	0.00187	CbGpPWpGaD
Amobarbital—GABRA5—Transmission across Chemical Synapses—PRKCB—stomach cancer	1.75e-05	0.00185	CbGpPWpGaD
Amobarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—stomach cancer	1.72e-05	0.00183	CbGpPWpGaD
Amobarbital—GABRA3—Transmission across Chemical Synapses—PRKCB—stomach cancer	1.72e-05	0.00182	CbGpPWpGaD
Amobarbital—CHRNA7—SIDS Susceptibility Pathways—TNF—stomach cancer	1.71e-05	0.00181	CbGpPWpGaD
Amobarbital—Pentobarbital—CYP2A6—stomach cancer	1.69e-05	0.572	CrCbGaD
Amobarbital—GABRA2—Transmission across Chemical Synapses—PRKCB—stomach cancer	1.69e-05	0.00179	CbGpPWpGaD
Amobarbital—GRIA2—BDNF signaling pathway—MAPK3—stomach cancer	1.69e-05	0.00179	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—ACAD8—stomach cancer	1.65e-05	0.00175	CbGpPWpGaD
Amobarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—stomach cancer	1.64e-05	0.00174	CbGpPWpGaD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—VEGFA—stomach cancer	1.62e-05	0.00172	CbGpPWpGaD
Amobarbital—GRIK2—Transmission across Chemical Synapses—MAPK1—stomach cancer	1.61e-05	0.00171	CbGpPWpGaD
Amobarbital—GRIA2—BDNF signaling pathway—MAPK1—stomach cancer	1.61e-05	0.0017	CbGpPWpGaD
Amobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—stomach cancer	1.59e-05	0.00169	CbGpPWpGaD
Amobarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—stomach cancer	1.57e-05	0.00166	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—IL6R—stomach cancer	1.56e-05	0.00165	CbGpPWpGaD
Amobarbital—GABRA6—Neuronal System—PRKCB—stomach cancer	1.53e-05	0.00162	CbGpPWpGaD
Amobarbital—GABRA4—Neuronal System—PRKCB—stomach cancer	1.51e-05	0.0016	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—GMPR2—stomach cancer	1.47e-05	0.00156	CbGpPWpGaD
Amobarbital—CHRNA7—Transmission across Chemical Synapses—MAPK1—stomach cancer	1.47e-05	0.00156	CbGpPWpGaD
Amobarbital—GABRA1—Transmission across Chemical Synapses—PRKCB—stomach cancer	1.44e-05	0.00153	CbGpPWpGaD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—TNF—stomach cancer	1.39e-05	0.00147	CbGpPWpGaD
Amobarbital—CHRNA7—SIDS Susceptibility Pathways—IL6—stomach cancer	1.38e-05	0.00146	CbGpPWpGaD
Amobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—stomach cancer	1.37e-05	0.00145	CbGpPWpGaD
Amobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—stomach cancer	1.35e-05	0.00143	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—SUCLG1—stomach cancer	1.35e-05	0.00143	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—IDH3B—stomach cancer	1.35e-05	0.00143	CbGpPWpGaD
Amobarbital—GABRA5—Neuronal System—PRKCB—stomach cancer	1.34e-05	0.00142	CbGpPWpGaD
Amobarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—stomach cancer	1.32e-05	0.0014	CbGpPWpGaD
Amobarbital—GABRA3—Neuronal System—PRKCB—stomach cancer	1.32e-05	0.0014	CbGpPWpGaD
Amobarbital—GRIK2—Transmission across Chemical Synapses—HRAS—stomach cancer	1.3e-05	0.00137	CbGpPWpGaD
Amobarbital—GABRA2—Neuronal System—PRKCB—stomach cancer	1.29e-05	0.00137	CbGpPWpGaD
Amobarbital—GRIA2—BDNF signaling pathway—HRAS—stomach cancer	1.29e-05	0.00137	CbGpPWpGaD
Amobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—stomach cancer	1.28e-05	0.00136	CbGpPWpGaD
Amobarbital—Phenobarbital—CYP2A6—stomach cancer	1.27e-05	0.428	CrCbGaD
Amobarbital—CYP2A6—Metabolism—NDUFS1—stomach cancer	1.25e-05	0.00133	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—NDUFV1—stomach cancer	1.25e-05	0.00133	CbGpPWpGaD
Amobarbital—GRIK2—Neuronal System—MAPK1—stomach cancer	1.24e-05	0.00131	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—CXCL8—stomach cancer	1.24e-05	0.00131	CbGpPWpGaD
Amobarbital—GRIA2—Transmission across Chemical Synapses—MAPK1—stomach cancer	1.23e-05	0.00131	CbGpPWpGaD
Amobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—stomach cancer	1.2e-05	0.00127	CbGpPWpGaD
Amobarbital—CHRNA4—Transmission across Chemical Synapses—MAPK1—stomach cancer	1.2e-05	0.00127	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—IL1B—stomach cancer	1.19e-05	0.00126	CbGpPWpGaD
Amobarbital—CHRNA7—Transmission across Chemical Synapses—HRAS—stomach cancer	1.18e-05	0.00125	CbGpPWpGaD
Amobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—stomach cancer	1.18e-05	0.00125	CbGpPWpGaD
Amobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—stomach cancer	1.16e-05	0.00123	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—JUN—stomach cancer	1.15e-05	0.00122	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—HMOX1—stomach cancer	1.14e-05	0.0012	CbGpPWpGaD
Amobarbital—CHRNA7—Neuronal System—MAPK1—stomach cancer	1.13e-05	0.00119	CbGpPWpGaD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—IL6—stomach cancer	1.12e-05	0.00119	CbGpPWpGaD
Amobarbital—GABRA4—Transmembrane transport of small molecules—HMOX1—stomach cancer	1.12e-05	0.00119	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—PGLS—stomach cancer	1.11e-05	0.00118	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—BLVRB—stomach cancer	1.11e-05	0.00118	CbGpPWpGaD
Amobarbital—GABRA1—Neuronal System—PRKCB—stomach cancer	1.1e-05	0.00117	CbGpPWpGaD
Amobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—stomach cancer	1.1e-05	0.00116	CbGpPWpGaD
Amobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—stomach cancer	1.08e-05	0.00115	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—PPAP2A—stomach cancer	1.06e-05	0.00113	CbGpPWpGaD
Amobarbital—GABRA6—Transmission across Chemical Synapses—MAPK1—stomach cancer	1.03e-05	0.00109	CbGpPWpGaD
Amobarbital—GABRA4—Transmission across Chemical Synapses—MAPK1—stomach cancer	1.01e-05	0.00108	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—VEGFA—stomach cancer	1e-05	0.00107	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—HMOX1—stomach cancer	9.97e-06	0.00106	CbGpPWpGaD
Amobarbital—GRIK2—Neuronal System—HRAS—stomach cancer	9.93e-06	0.00105	CbGpPWpGaD
Amobarbital—GRIA2—Transmission across Chemical Synapses—HRAS—stomach cancer	9.91e-06	0.00105	CbGpPWpGaD
Amobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—stomach cancer	9.86e-06	0.00105	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—HMOX1—stomach cancer	9.79e-06	0.00104	CbGpPWpGaD
Amobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—stomach cancer	9.62e-06	0.00102	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—HMOX1—stomach cancer	9.62e-06	0.00102	CbGpPWpGaD
Amobarbital—CHRNA4—Transmission across Chemical Synapses—HRAS—stomach cancer	9.62e-06	0.00102	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—NDUFA2—stomach cancer	9.48e-06	0.001	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—CKB—stomach cancer	9.48e-06	0.001	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—FBP1—stomach cancer	9.48e-06	0.001	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—CA1—stomach cancer	9.48e-06	0.001	CbGpPWpGaD
Amobarbital—GRIA2—Neuronal System—MAPK1—stomach cancer	9.46e-06	0.001	CbGpPWpGaD
Amobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—stomach cancer	9.45e-06	0.001	CbGpPWpGaD
Amobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—stomach cancer	9.29e-06	0.000984	CbGpPWpGaD
Amobarbital—CHRNA4—Neuronal System—MAPK1—stomach cancer	9.18e-06	0.000973	CbGpPWpGaD
Amobarbital—CHRNA7—Neuronal System—HRAS—stomach cancer	9.04e-06	0.000958	CbGpPWpGaD
Amobarbital—GABRA5—Transmission across Chemical Synapses—MAPK1—stomach cancer	9.01e-06	0.000955	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—PLIN2—stomach cancer	8.91e-06	0.000945	CbGpPWpGaD
Amobarbital—GABRA3—Transmission across Chemical Synapses—MAPK1—stomach cancer	8.85e-06	0.000938	CbGpPWpGaD
Amobarbital—GABRA2—Transmission across Chemical Synapses—MAPK1—stomach cancer	8.7e-06	0.000922	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—CA2—stomach cancer	8.67e-06	0.000919	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—TNF—stomach cancer	8.61e-06	0.000913	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—APOA1—stomach cancer	8.61e-06	0.000913	CbGpPWpGaD
Amobarbital—GABRA4—Transmembrane transport of small molecules—APOA1—stomach cancer	8.5e-06	0.000901	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—NT5E—stomach cancer	8.45e-06	0.000896	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—PGAM1—stomach cancer	8.45e-06	0.000896	CbGpPWpGaD
Amobarbital—GABRA6—Transmission across Chemical Synapses—HRAS—stomach cancer	8.25e-06	0.000874	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—HMOX1—stomach cancer	8.2e-06	0.000869	CbGpPWpGaD
Amobarbital—GABRA4—Transmission across Chemical Synapses—HRAS—stomach cancer	8.14e-06	0.000863	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—ALDH7A1—stomach cancer	8.06e-06	0.000854	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—PLCE1—stomach cancer	8.06e-06	0.000854	CbGpPWpGaD
Amobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—stomach cancer	7.92e-06	0.000839	CbGpPWpGaD
Amobarbital—GABRA6—Neuronal System—MAPK1—stomach cancer	7.87e-06	0.000834	CbGpPWpGaD
Amobarbital—GABRA4—Neuronal System—MAPK1—stomach cancer	7.77e-06	0.000824	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—UMPS—stomach cancer	7.73e-06	0.000819	CbGpPWpGaD
Amobarbital—GRIA2—Neuronal System—HRAS—stomach cancer	7.6e-06	0.000805	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—APOA1—stomach cancer	7.55e-06	0.000801	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—APOA1—stomach cancer	7.42e-06	0.000786	CbGpPWpGaD
Amobarbital—GABRA1—Transmission across Chemical Synapses—MAPK1—stomach cancer	7.41e-06	0.000786	CbGpPWpGaD
Amobarbital—CHRNA4—Neuronal System—HRAS—stomach cancer	7.37e-06	0.000781	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—APOA1—stomach cancer	7.29e-06	0.000773	CbGpPWpGaD
Amobarbital—GABRA5—Transmission across Chemical Synapses—HRAS—stomach cancer	7.23e-06	0.000767	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—PDHA1—stomach cancer	7.18e-06	0.000762	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—ECHS1—stomach cancer	7.18e-06	0.000762	CbGpPWpGaD
Amobarbital—GABRA3—Transmission across Chemical Synapses—HRAS—stomach cancer	7.1e-06	0.000753	CbGpPWpGaD
Amobarbital—GABRA2—Transmission across Chemical Synapses—HRAS—stomach cancer	6.98e-06	0.00074	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—IL6—stomach cancer	6.95e-06	0.000737	CbGpPWpGaD
Amobarbital—GABRA5—Neuronal System—MAPK1—stomach cancer	6.9e-06	0.000732	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—ALB—stomach cancer	6.82e-06	0.000723	CbGpPWpGaD
Amobarbital—GABRA3—Neuronal System—MAPK1—stomach cancer	6.78e-06	0.000719	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—TYMP—stomach cancer	6.75e-06	0.000716	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—FADS1—stomach cancer	6.75e-06	0.000716	CbGpPWpGaD
Amobarbital—GABRA4—Transmembrane transport of small molecules—ALB—stomach cancer	6.73e-06	0.000714	CbGpPWpGaD
Amobarbital—GABRA2—Neuronal System—MAPK1—stomach cancer	6.66e-06	0.000706	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—SREBF2—stomach cancer	6.32e-06	0.00067	CbGpPWpGaD
Amobarbital—GABRA6—Neuronal System—HRAS—stomach cancer	6.32e-06	0.00067	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—RORA—stomach cancer	6.25e-06	0.000662	CbGpPWpGaD
Amobarbital—GABRA4—Neuronal System—HRAS—stomach cancer	6.24e-06	0.000661	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—APOA1—stomach cancer	6.22e-06	0.000659	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—ALB—stomach cancer	5.98e-06	0.000634	CbGpPWpGaD
Amobarbital—GABRA1—Transmission across Chemical Synapses—HRAS—stomach cancer	5.95e-06	0.000631	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—ALB—stomach cancer	5.88e-06	0.000623	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—ALDOB—stomach cancer	5.86e-06	0.000621	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—ALB—stomach cancer	5.77e-06	0.000612	CbGpPWpGaD
Amobarbital—GABRA1—Neuronal System—MAPK1—stomach cancer	5.68e-06	0.000602	CbGpPWpGaD
Amobarbital—GABRA5—Neuronal System—HRAS—stomach cancer	5.54e-06	0.000588	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—ALOX5—stomach cancer	5.44e-06	0.000577	CbGpPWpGaD
Amobarbital—GABRA3—Neuronal System—HRAS—stomach cancer	5.44e-06	0.000577	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—DPYD—stomach cancer	5.36e-06	0.000568	CbGpPWpGaD
Amobarbital—GABRA2—Neuronal System—HRAS—stomach cancer	5.35e-06	0.000567	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—ALB—stomach cancer	4.92e-06	0.000522	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—GSTT1—stomach cancer	4.74e-06	0.000502	CbGpPWpGaD
Amobarbital—GABRA1—Neuronal System—HRAS—stomach cancer	4.56e-06	0.000484	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—AKR1C3—stomach cancer	4.55e-06	0.000483	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—ENO1—stomach cancer	4.44e-06	0.00047	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—CD44—stomach cancer	3.94e-06	0.000417	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—PPP2R1A—stomach cancer	3.35e-06	0.000355	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—GSTP1—stomach cancer	3.28e-06	0.000348	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—HMOX1—stomach cancer	3.24e-06	0.000343	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—TYMS—stomach cancer	3.05e-06	0.000324	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—GSTM1—stomach cancer	3.02e-06	0.00032	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—ERCC2—stomach cancer	2.84e-06	0.000301	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—MTHFR—stomach cancer	2.67e-06	0.000283	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—CAV1—stomach cancer	2.46e-06	0.000261	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—APOA1—stomach cancer	2.45e-06	0.00026	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—PPARG—stomach cancer	2.16e-06	0.000229	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—ALB—stomach cancer	1.94e-06	0.000206	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—NOS3—stomach cancer	1.86e-06	0.000197	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—PTGS2—stomach cancer	1.7e-06	0.00018	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—PIK3CA—stomach cancer	1.05e-06	0.000111	CbGpPWpGaD
